about
Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.Implementation of the external cephalic version in breech delivery. Dutch national implementation study of external cephalic version.Low dose aspirin in the prevention of recurrent spontaneous preterm labour - the APRIL study: a multicenter randomized placebo controlled trial.Mode of delivery after successful external cephalic version: a systematic review and meta-analysis.Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)Prediction models for successful external cephalic version: a systematic review.Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).Tobacco control policies and perinatal health: a national quasi-experimental studyClinical factors to predict the outcome of external cephalic version: a metaanalysis.External cephalic version-related risks: a meta-analysis.Contraindications for external cephalic version in breech position at term: a systematic review.Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.Term breech deliveries in the Netherlands: did the increased cesarean rate affect neonatal outcome? A population-based cohort study.External validation of a prediction model for successful external cephalic version.Nifedipine as a uterine relaxant for external cephalic version: a randomized controlled trial.Which Factors Contribute to False-Positive, False-Negative, and Invalid Results in Fetal Fibronectin Testing in Women with Symptoms of Preterm Labor?Risk factors for cesarean section and instrumental vaginal delivery after successful external cephalic version.Preterm Breech Presentation: A Comparison of Intended Vaginal and Intended Cesarean Delivery.Preterm birth in singleton and multiple pregnancies: evaluation of costs and perinatal outcomes.Comment on: a meta-analysis of common risk factors associated with the diagnosis of developmental dysplasia of the hip in newborns.Risks of vaginal breech delivery at term compared with elective cesarean section - reply to comments by Walker and Powell, and Sholapurkar.Subsequent pregnancy outcome after preterm breech delivery, a population based cohort study.Expectant parents' preferences for mode of delivery and trade-offs of outcomes for breech presentation.Implementation of client versus care-provider strategies to improve external cephalic version rates: a cluster randomized controlled trial.Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.Nifedipine Versus Atosiban for Threatened Preterm Birth (APOSTEL III)362: Does quantitative fetal fibronectin testing add to cervical length measurement and qualitative fetal fibronectin testing; (I) Identification of low risk women with threatened preterm labor (EUFIS study)5: Nifedipine versus atosiban for tocolysis in preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-trial)Risks of vaginal breech delivery at term compared to elective cesarean section--reply to comment by PageWhich factors play a role in clinical decision-making in external cephalic version?[The many manifestations of Behçet's disease]
P50
Q30356565-A71EDB22-AC89-484F-9E02-6AD1CE1425B6Q33575308-5924BF29-56DB-4F7C-A8C1-01FA81B8F13FQ33910448-0E35CEA3-9B15-49A8-A18F-35AAC773C018Q34419268-BFA87096-2B25-4DDC-8535-747F85216742Q35109526-AB4E57F1-399C-4573-B63A-1AFBB77E8477Q35835014-CD0E414B-C74D-486A-89EA-63EE734E42FCQ35906606-865C4850-83AF-4323-9543-DBC4B7498B72Q36074052-E7E95196-5A62-405F-BBC6-7EA2F3C3FDF8Q36824051-43401BD2-589D-49A5-9053-917B62E1737AQ37154422-934BA743-DE46-4E7E-89BA-B7F0D791C612Q37315020-8A7EBB63-B40D-4CB6-9E4A-22CFA583E22AQ38045001-D392B6B4-0FE9-40BE-BF43-F0F443930C69Q38899792-2BACB166-19A7-4235-92EB-732E0784ED73Q39146201-286A4043-7C3E-473B-B299-E1680DE37114Q39721983-2D7B91EF-5B67-4BC9-A5D8-95E29EAE8651Q40064463-E21D5FA1-79D6-417F-8F40-906C98F448CFQ40391731-E352FFA4-EAC0-4FE6-ADCE-FE2EEE2F370BQ40581219-F13979F0-A9D6-4E6E-93F4-951082F10DA9Q41138622-F6F456B4-93D7-4B81-8B60-9D6B824D61F1Q41536710-3DFEE230-5D3D-4909-9CA5-008422967F0BQ44733320-7F3EDB7B-6BC6-4ABB-BA99-400C0EDC33D5Q45111809-16465CF2-76EF-491B-B149-FA8E2FCEBFE0Q46310549-6962D0A1-EC5D-47E1-980C-E02F1FD10AE9Q46336325-1DC20081-48A0-4F3D-9379-18A343BDE28BQ51008171-57BE5966-3239-418D-B230-FC5D14E30D8BQ53578415-B4C64197-CC62-417D-8E55-D7EA6E924CB4Q53728652-892B0CC5-D8DD-431B-B29A-3F506B162543Q60226755-43C479A5-919A-44DF-A70F-3BC02129E34CQ60226772-3E656294-29B6-4345-8C06-1AC9FFE15043Q60226781-CFFF9FFA-0CA5-4D8D-9B1F-C02E5700435EQ61839102-D29038BF-B168-4AD2-ADBD-6E53F24181C7Q81489323-9D678CE8-39A0-4702-AC5F-80A4396127ECQ82206068-65F24160-6F4E-4EF5-9F50-0DE4C6AB41A3
P50
name
Marjolein Kok
@en
type
label
Marjolein Kok
@en
prefLabel
Marjolein Kok
@en